Author

G. D. A. Guardia

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Research Focus:differential expression· 3 Organism:human· 3 Approach:statistical model· 3 Research Focus:gene regulatory network inference· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:experimental assay· 1

Frequent Co-Authors

P. A. F. Galante· 3 shared L. O. Penalva· 2 shared A. Savio· 1 shared B. Malnic· 1 shared F. M. Meliso· 1 shared H. B. Conceicao· 1 shared I. Zalcberg· 1 shared J. B. da Costa· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

P. A. F. Galante

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyRNA BiologyPeer-reviewedDec 31, 2023

The paralogues MAGOH and MAGOHB are oncogenic factors in high-grade gliomas and safeguard the splicing of cell division and cell cycle genes

R. A. S. Barreiro, G. D. A. Guardia, F. M. Meliso…·P. A. F. Galante

This study identifies MAGOH and MAGOHB as oncogenic factors in high-grade gliomas that safeguard splicing of cell division and cell cycle genes, with high expression linked to poor prognosis.

DOI 10.1080/15476286.2023.2221511

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJul 14, 2023

Unveiling the role of SRY in male-biased cancers: Insights into the molecular basis of sex disparities in high-grade glioma and melanoma

G. D. A. Guardia, R. L. Batista, L. O. Penalva, P. A. F. Galante

The paper investigates SRY gene expression in high-grade glioma and melanoma, finding higher SRY expression correlates with worse prognosis in men and links to altered gene expression related to cell growth and tumor suppression.

DOI 10.1101/2023.07.14.548747

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivApr 12, 2022

Acute myeloid leukemia expresses a specific group of olfactory receptors

G. D. A. Guardia, R. N. Goncalves, V. C. Buzatto…·P. A. F. Galante

This study identifies a group of olfactory receptors specifically expressed in AML samples and shows their potential as biomarkers and drug targets.

DOI 10.3390/cancers15123073

humanbulk RNA-seq

𝕏 PostBluesky